About the Meeting.
The field of genetics has recently reached a critical milestone, with the discovery and ever-growing successful usage of the so-called “CRISPR” technology. Although its discovery dates back to work published in the early 1990s, its application to a robust and efficient genome editing tool was reported recently, in a series of landmark papers published in 2013.
Since then, CRISPR-based approaches have blossomed remarkably fast and are implemented in many laboratories around the world, working on a broad range of biological, biomedical, and agricultural issues. Analogous the PCR revolution witnessed by biologists in the 1980s, CRISPR clearly stands out as a novel chapter in the major biotechnology revolution which our century is witnessing. The extraordinary efficiency and ease of implementation of CRISPR approaches allows rapid candidate or genome-wide reverse genetics, in virtually any organism, well beyond standard laboratory model systems.
For these reasons, the French Society for Genetics (SFG) has chosen to devote its Annual Meeting to the fundamental contribution of CRISPR to the broad field of genetics, both for bacterial immunity and as a genome engineering technology.
The meeting starts with an exceptional outreach event, which is open to a wide audience, particularly non-scientists. A conference by Christian Siatka (Ecole de l’ADN, Nimes) will cover societal and ethical aspects that will be then further discussed during open round tables.
The scientific program features prestigious speakers, including a keynote address by Ben Davies (Wellcome Trust Centre for Human Genetics, Oxford), whose seminal work has been crucial to translating the bacterial CRIPSR system into a genome editing tool.
The meeting is organized into three distinct sessions.
- Session 1, entitled “Bacterial Immunity and Beyond” and led by Sylvain Moineau (Laval University, Québec), will cover basic research on bacterial immunity, which has to the initial discovery of the CRISPR system and continues to bring novel insights into its diversity and function.
- Session 2, entitled “Developmental and Physiological Genetics” and led by Norbert Perrimon (Harvard Medical School, Boston), will showcase recent discoveries that have been made using innovative CRISPR-based genetic tools, including controlled epigenetic modifications in Drosophila.
- Session 3, entitled “From Functional Genomics to Applications” and led by Fabien Nogué (INRA, Versailles), will notably report the perspectives offered by the CRISPR technology for generating new characteristics in species that have agronomic and economic importance.
We are looking forward to seeing many of you in Montpellier next November, for what promises to be an exciting scientific conference!
The organizing committee.
Dr Frédéric Baudat, CNRS, Montpellier
Pr Bernard Dujon, Institut Pasteur, Paris
Dr Dom Helmlinger, CNRS, Montpellier
Dr Sarah Lambert, Institut Curie, Orsay
Pr Anne-Marie Martinez, Univ. Montpellier
Dr Nicolas Nègre, Univ. Montpellier
Dr Alain Nicolas, Institut Curie, Paris
Dr Simonetta Piatti, CNRS, Montpellier
Dr Christian Siatka, Univ. Nîmes
Dr Thomas Robert, CNRS, Montpellier
Dr Charles White, CNRS, Clermont-Ferrand
@ Montpellier, Fr
- Isabelle Busseau (IGH, Montpellier)
- Dom Helmlinger (CRBM, Montpellier)
- Catherine Larose (IGH, Montpellier)
- Anne-Marie Martinez (UM, Montpellier)
- Nicolas Nègre (UM, Montpellier)
- Cyril Sarrauste (IGH, Montpellier)
- Christian Siatka (Ecole ADN, Nîmes)